Prescribing guidelines
Loading…
You will be guided to the Medicines Optimisation page. The relevant document should be top of the list
-
CVS: NOACS Management of bleeding with Direct Oral Anticoagulants
Cardiovascular and Lipids
Laboratory investigations and Infections
-
CVS: Spironolactone - Position Statement on MHRA Drug Safety Update
Cardiovascular and Lipids
-
CVS: Switching Between Oral Anticoagulants
Cardiovascular and Lipids
-
CVS: Ticagrelor guidelines
Cardiovascular and Lipids
-
Diabetes: Antiplatelet treatment in diabetes
Cardiovascular and Lipids
Endocrine and Diabetes
-
Lipid management for Secondary Prevention of CVD
Cardiovascular and Lipids
-
Lipid Management for Primary Prevention of CVD in Adults
Cardiovascular and Lipids
-
Lipid Optimisation in Primary and Secondary Prevention of CVD
Cardiovascular and Lipids
-
SGLT2 inhibitor first line treatment for patients with type 2 diabetes (with or without chronic kidney disease) and/or heart failure,
Cardiovascular and Lipids
Endocrine and Diabetes
-
Tirzepatide- Primary Care weight management Quick reference Guidelines
Cardiovascular and Lipids
Endocrine and Diabetes
Gastroenterology
Did you find this page helpful?